171 related articles for article (PubMed ID: 22136882)
1. Metabolomic biomarkers of impaired glucose tolerance and type 2 diabetes mellitus with a potential for risk stratification in women with polycystic ovary syndrome.
Galazis N; Iacovou C; Haoula Z; Atiomo W
Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):121-30. PubMed ID: 22136882
[TBL] [Abstract][Full Text] [Related]
2. Impaired glucose metabolism in women with polycystic ovary syndrome.
Vrbikova J; Fanta M; Cibula D; Vondra K; Bendlova B
Gynecol Obstet Invest; 2009; 68(3):186-90. PubMed ID: 19672087
[TBL] [Abstract][Full Text] [Related]
3. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
Tomlinson J; Millward A; Stenhouse E; Pinkney J
Diabet Med; 2010 May; 27(5):498-515. PubMed ID: 20536945
[TBL] [Abstract][Full Text] [Related]
5. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression.
Kakoly NS; Khomami MB; Joham AE; Cooray SD; Misso ML; Norman RJ; Harrison CL; Ranasinha S; Teede HJ; Moran LJ
Hum Reprod Update; 2018 Jul; 24(4):455-467. PubMed ID: 29590375
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome.
Espinós-Gómez JJ; Corcoy R; Calaf J
Gynecol Endocrinol; 2009 Mar; 25(3):199-204. PubMed ID: 19347711
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome.
Trakakis E; Basios G; Peppa M; Simeonidis G; Labos G; Creatsa M; Misailidou M; Boutati E; Vaggopoulos V; Panagopoulos P; Dimitriades G; Kassanos D
Gynecol Endocrinol; 2012 Nov; 28(11):867-70. PubMed ID: 22571176
[TBL] [Abstract][Full Text] [Related]
9. Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetes.
Love-Osborne K; Butler N; Gao D; Zeitler P
Pediatr Diabetes; 2006 Aug; 7(4):205-10. PubMed ID: 16911007
[TBL] [Abstract][Full Text] [Related]
10. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in lipid profiles in relation to the progression of glucose abnormalities.
Carnevale Schianca GP; Fra GP; Colli E; Bigliocca M; Mella R; Scaglia E; Bartoli E
J Diabetes; 2012 Mar; 4(1):95-101. PubMed ID: 21951548
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann DA; Barnes RB; Rosenfield RL; Cavaghan MK; Imperial J
Diabetes Care; 1999 Jan; 22(1):141-6. PubMed ID: 10333916
[TBL] [Abstract][Full Text] [Related]
13. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
14. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
Guerrero-Romero F; Rodríguez-Morán M
Eur J Clin Invest; 2006 Nov; 36(11):796-802. PubMed ID: 17032347
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
[TBL] [Abstract][Full Text] [Related]
16. Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome--a long term follow-up.
Hudecova M; Holte J; Olovsson M; Larsson A; Berne C; Poromaa IS
Hum Reprod; 2011 Jun; 26(6):1462-8. PubMed ID: 21427116
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of glucose metabolism in non-obese and obese women with polycystic ovarian syndrome].
Shi YH; Zhao DN; Zhao JL; You L; Liu H; Sun M; Chen ZJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):575-7. PubMed ID: 21029611
[TBL] [Abstract][Full Text] [Related]
18. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
19. Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.
Sanusi H
Acta Med Indones; 2004; 36(1):36-41. PubMed ID: 15673935
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and characteristics of impaired glucose metabolism in patients referred to comprehensive cardiac rehabilitation: the DANSUK study.
Boas Soja AM; Zwisler AD; Melchior T; Hommel E; Torp-Pedersen C; Madsen M
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):784-90. PubMed ID: 17001219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
